Azitra, Inc.

AZTR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Sep 2025 Jun 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Revenue $0 $0 $0 $0 $7.5K $0 $90.0K $310.7K
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development $1.2M $1.4M $1.1M $1.0M $1.1M $1.5M $1.5M $548.5K
SG&A Expense $1.6M $1.5M $1.3M $1.9M $1.5M $1.5M $1.0M $1.8M
Operating Income $-2.8M $-2.9M $-2.4M $-2.9M $-2.7M $-3.0M $-2.5M $-2.0M
Operating Margin — — — — -35,470.4% — -2,745.0% -641.7%
Interest Expense — — — — — $915 $997 $710
Pretax Income $-2.8M $-2.9M $-2.4M $-1.0M $-2.6M $-2.9M $-2.4M $-1.9M
Income Tax Expense $0 $0 $9.0K $0 $0 $0 $7.6K $0
Net Income $-2.8M $-2.9M $-2.4M $-1.0M $-2.6M $-2.9M $-2.5M $-1.9M
Net Margin — — — — -35,093.2% — -2,726.4% -625.5%
EPS (Basic) $-0.07 $-0.13 $-0.83 $-0.06 $-0.15 $-0.24 $1.32 $-0.27
EPS (Diluted) $-0.07 $-0.13 $-0.83 $-0.06 $-0.15 $-0.24 $1.32 $-0.27
Shares Outstanding (Basic) 37.1M 22.0M 5.1M 15.9M 17.3M 12.2M 4.1M 7.3M
Shares Outstanding (Diluted) 37.1M 22.0M 5.1M 15.9M 17.3M 12.2M 4.1M 7.3M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →